Advisory Services Network, LLC
Position in ESPR — Esperion Therapeutics, Inc.
CIK 1573876
Atlanta, GA
Position in ESPR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
2,050
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Advisory Services Network, LLC holds $13,295,345 across 12 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
48,150 | $3,838,999 | |
| 2 | ZTS |
Zoetis Inc.
|
35,783 | $2,571,361 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
54,094 | $1,875,438 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
41,526 | $1,406,898 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
48,865 | $1,202,563 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
55,150 | $884,053 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
1,187 | $643,150 | |
| 8 | HLN |
Haleon plc
|
34,165 | $318,754 |
All Filings in ESPR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 2,050 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | — | 2,050 | Shares | Sole | 2025-11-18 | |
| 2023-12-31 | — | 62 | Shares | Sole | 2024-02-09 | |
| 2023-03-31 | — | 1,112 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | — | 112 | Shares | Sole | 2023-02-13 | |
| 2020-09-30 | — | 51 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||